Perioperative Management of Adult COVID-19 Suspected or Positive Patient: A literature review of Available Evidences
Keywords:
COVID-19, Pandemics, operation room management, tracheostomy, anaesthesiology and emergencies.Abstract
Novel corona virus disease (SARS-CoV-2) has been declared a pandemic
affecting over 100 countries and 34 million people globally. Though
majority develop mild clinical constitutional symptoms, a significant
number of patients manifest severe respiratory illness. The current
(or future) pandemic situation can potentially overwhelm the health
care resources in the coming times and may impair the delivery of
optimal care to patients requiring surgical interventions. Planned and
judicious utilization of manpower and resources is of prime importance.
Routine or elective surgical procedures should be triaged and deferred
and only emergency and time sensitive surgical interventions are
allowed till epidemic is contained. Airway intervention during general
anesthesia is a high-risk aerosol generating procedure (AGP) which
exposes the anaesthesiologists to airborne particles with potential risk
of transmission of COVID. It is therefore one of the most critical steps
in the management of such a patient. Regional anaesthesia should be
preferred for providing anesthesia care whenever possible considering
the increased risk of exposure of anesthesiologist to virus during general
anaesthesia (GA). This article attempts to discuss the basic epidemiology,
pathology, presentation of COVID-19 along with the considerations
for operating room preparedness, personal protective equipment
required, anaesthesia conduct, waste disposal while managing a COVID
positive or suspected case. We have also deliberated upon the specific
considerations for a COVID patient undergoing regional anaesthesia,
tracheostomy, COVID parturient and trauma emergencies.
How to cite this article:
Nath S, Choudhury A, Gupta A, Gupta N.
Perioperative Management of Adult COVID-19
Suspected or Positive Patient: A literature
review of Available Evidences. Rec Adv Path
Lab Med. 2023;9(3&4):14-28.
DOI: https://doi.org/10.24321/2454.8642.202307
References
https://www.who.int/emergencies/diseases/novel-
coronavirus-2019/situation-reports.
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z,
Bibi S, et al. The SARS, MERS and novel coronavirus
(COVID-19) epidemics, the newest and biggest global
health threats: what lessons have we learned? Int J
Epidemiol. 2020 Feb 22;dyaa033.
Wang C, Horby PW, Hayden FG, Gao GF. A novel
coronavirus outbreak of global health concern. Lancet
Lond Engl. 2020;395:470–3.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Recent Advances in Pathology and Laboratory Medicine ( ISSN: 2454-8642 )
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
